SCHEMBL4068157

SCHEMBL4068157

C#CCNc1nc(Nc2ccc(S(N)(=O)=O)cc2)ncc1I

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.78
CA1 P00915 5/20 0.54
CA9 Q16790 5/20 0.54
CA12 O43570 2/20 0.54
CDK2 P24941 6/20 0.53
CDK1 P06493 5/20 0.53
CCNB1 P14635 3/20 0.53
CCNE1 P24864 2/20 0.53
CDK7 P50613 3/20 0.51
CDK9 P50750 3/20 0.51
KDR P35968 3/20 0.51
CDK4 P11802 2/20 0.51
CCNT1 O60563 2/20 0.51
CCNH P51946 2/20 0.51
CCND1 P24385 1/20 0.51
PTK2 Q05397 3/20 0.48
AURKA O14965 1/20 0.48
AURKB Q96GD4 1/20 0.48
NTRK1 P04629 1/20 0.47
CA4 P22748 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4063385 0.87 CA2 (1.00) CA2CA1CA9CA12CDK2
SCHEMBL13648578 0.87 CA2 (0.79) CA2CA1CA9CA12CDK2
SCHEMBL4019284 0.86 CA2 (0.78) CA2CA1CA9CA12CDK2
SCHEMBL4058941 0.86 CA2 (0.78) CA2CA1CA9CA12CDK2
SCHEMBL4018940 0.86 CA2 (0.78) CA2CA1CA9CA12CDK2
SCHEMBL4026166 0.81 CDK1 (0.51) CA2CDK2CDK1CCNB1CCNE1
SCHEMBL13442815 0.79 CDK2 (0.59) CA2CDK2CDK1CCNB1CCNE1
SCHEMBL5174690 0.76 CDK2 (0.63) CA2CA1CA9CDK2CDK1
SCHEMBL4020087 0.76 CDK2 (0.63) CA2CA1CA9CDK2CDK1
SCHEMBL1474323 0.76 CA2 (0.62) CA2CA1CA9CA12CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 EP claimed
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 EP disclosed